TRIAMCINOLONE DISCONTINUED (is an active metabolite) ![](https://chemoinfo.ipmc.cnrs.fr/MOLDB/MOL_PNG/drug/img_224_mol.png)
| TRIAMCINOLONE | ATC A01AC01 ATC C05AA12 ATC D07AB09 ATC D07XB02 ATC H02AB08 ATC R01AD11 ATC R03BA06 ATC S01BA05 ATC D07CB01 ATC S02CA04 ATC D07BB03
RESPIRATORY SYSTEM GLUCOCORTICOID ANTI-INFLAMMATORY AGENTS | ORAL | Tmax 1.9 HOUR HT 2.7 HOUR (PMID3245858) | GLUCOCORTICOID RECEPTOR | GLUCOCORTICOID RECEPTOR AGONIST CHEMBL2034 GLUCOCORTICOID RECEPTOR P04150 GLUCOCORTICOID RECEPTOR HOMO SAPIENS TRANSCRIPTION FACTOR NUCLEAR RECEPTOR NR3 NR3C NR3C1 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |
TRIAMCINOLONE HEXACETONIDE DISCONTINUED (has an active metabolite) ![](https://chemoinfo.ipmc.cnrs.fr/MOLDB/MOL_PNG/drug/img_1341_mol.png)
| TRIAMCINOLONE HEXACETONIDE | ATC A01AC01 ATC C05AA12 ATC D07AB09 ATC D07XB02 ATC H02AB08 ATC R01AD11 ATC R03BA06 ATC S01BA05 ATC D07CB01 ATC S02CA04 ATC D07BB03
GLUCOCORTICOID AGONIST ANTI-INFLAMMATORY AGENTS ALOPECIA AREATA CYSTIC TUMORS OF AN APONEUROSIS OR TENDON (GANGLIA) ECZEMA PSORIASIS ARTHRITIS ALLERGIES ULCERATIVE COLITIS LUPUS SYMPATHETIC OPHTHALMIA TEMPORAL ARTERITIS UVEITIS OCULAR INFLAMMATION
| INJECTION | SOLUBILITY RELATIVELY INSOLUBLE 0.0002 PERCENT AT 25 DEGRE CELSIUS IN WATER | GLUCOCORTICOID RECEPTOR | GLUCOCORTICOID RECEPTOR AGONIST CHEMBL2034 GLUCOCORTICOID RECEPTOR P04150 GLUCOCORTICOID RECEPTOR HOMO SAPIENS TRANSCRIPTION FACTOR NUCLEAR RECEPTOR NR3 NR3C NR3C1 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |